
Turn Therapeutics Announces Q1 2026 Financial Results and Corporate Updates
Turn Therapeutics Publishes First Quarter 2026 Results Alongside Company Updates Turn Therapeutics a clinical-stage biotechnology company focused on developing targeted inflammatory and immunological therapies for dermatologic diseases, has reported its financial results for the first quarter ended March 31, 2026,…












